Kiora Pharmaceuticals INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Kiora Pharmaceuticals announces its 2026 Annual Meeting of Stockholders to be held on June 10, 2026, featuring proposals for director elections, executive compensation, and an equity plan amendment.
NASDAQ
Kiora Pharmaceuticals will hold its 2025 Annual Meeting of Stockholders on June 4, 2025, to elect directors, approve executive compensation, and ratify the appointment of its accounting firm.
NASDAQ
Kiora Pharmaceuticals is asking stockholders to vote on proposals including a reverse stock split, increasing authorized shares, approving a new equity incentive plan, and other corporate governance matters at its upcoming annual meeting.